China Syringe Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Insulin Syringe, Conventional Syringe), By Material (Glass, Plastic, Stainless Steel), By Syringe Size (Smaller Volume Syringe, Larger Volume Syringe) - Forecasts From 2023 To 2028

The Chinese syringe market is growing due to increasing demand for medical equipment. This is on account of the aging population and the country's efforts to improve its healthcare system. The country is one of the largest manufacturers and suppliers of syringes globally, with a significant market share. Chinese syringe manufacturers produce a wide range of syringes, including disposable syringes, safety syringes, and insulin syringes, intravenous syringes.

The Chinese government's investments in the healthcare sector and initiatives to promote vaccination programs have also contributed to market growth in the country. In addition, the increasing demand for low-cost medical devices has also further driven this growth. However, the market faces certain challenges such as stringent regulations, quality control issues, and the presence of counterfeit products. Despite these challenges, the market is expected to grow in the coming years, driven by factors such as increasing investment in research and development, rising awareness about hygiene and safety in medical procedures, and the growth of the healthcare sector in China.

Key Drivers

Increasing Demand for Medical Equipment

China has one of the world's largest aging populations, and the number of elderly people in the country is expected to continue to grow in the coming years. As people age, they are more likely to develop chronic diseases such as diabetes, cardiovascular diseases, and cancer and require medical equipment, including syringes, for treatment and management. There is growing awareness about health and wellness in China, and more people are seeking medical equipment, including syringes, for preventive healthcare and self-monitoring. 

Investment in research and development

Investment in research and development is also allowing manufacturers in China to develop new and innovative products, such as safety syringes, disposable syringes, and insulin syringes, to meet the growing demand for medical equipment. And they are working to improve the quality of their syringes, making them safer, more effective, and more efficient. As a result, Jiangxi Sanxin Medtec Co, the large syringe producer, is dealing with strong orders.

In addition, one of the main ways in which rising awareness about hygiene and safety is influencing the Chinese syringe market is through increased demand for safe syringes. These syringes are designed to prevent the spread of infections by reducing the risk of needlestick injuries and cross-contamination, manufacturers in China are focusing more on quality control, ensuring that their syringes meet the highest standards of safety and efficacy.

Key developments

• In 2020, Sanofi and Regeneron Pharmaceuticals received approval from China's National Medical Products Administration (NMPA) for their drug, Dupixent (dupilumab), in the treatment of moderate-to-severe atopic dermatitis (AD) which is available as a 300mg dose pre-filled syringe is a positive step towards meeting the needs of patients in China with moderate-to-severe atopic dermatitis.
• In 2022, EyePoint Pharmaceuticals, Inc. and OcuMension Therapeutics received approval from China's Center for Drug Evaluation (CDE) for their drug, DEXYCU (dexamethasone intraocular suspension) 9% for intravitreal injection. DEXYCU is a novel, sustained-release drug for the treatment of postoperative inflammation and pain following cataract surgery.

China Syringe Market Scope:

Segmentation

• By Type
  • Insulin Syringe
  • Conventional Syringe
    • Eccentric Tip Syringe
    • Catheter Tip Syringe
    • Luer Lock Syringe
• By Material
  • Glass
  • Plastic
  • Stainless Steel
• By Syringe Size
  • Smaller Volume Syringe
  • Larger Volume Syringe